5-10 business days

Bavdegalutamide (ARV-110) is a PROTAC protein degrader for prostate cancer. Bavdegalutamide promotes ubiquitination and degradation of androgen receptor (AR). Reference: Taavi Neklesa, Lawrence B. Snyder, Ryan R. Willard, Nicholas Vitale, Kanak Raina, Jennifer Pizzano, Deborah Gordon, Mark Bookbinder, Jennifer Macaluso, Hanqing Dong, Zheng Liu, Caterina Ferraro, Gan Wang, Jing Wang, Craig M. Crews, John Houston, Andrew P. Crew, Ian Taylor. ARV-110: An androgen receptor PROTAC degrader for prostate cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 5236.

Product Name Bavdegalutamide
Synonyms ARV-110
CAS Number 2222112-77-6
Related CAS
Molecular Formula C41H43ClFN9O6
Molecular Weight 812.3
Purity (HPLC) 98%
Shipping Conditions Room Temperature
Storage Conditions Refrigerated
Regulatory Statemen: For Research Use Only